Location: Home >> Editorial Board
Professor of Clinical Proteomics and Structural Biology China
Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University
disease proteomics, biomarkers and structural biology
Dr. Xianquan Zhan is a Professor at the Key Laboratory of Cancer Proteomics of Chinese Ministry of China, Hunan Engineering Laboratory for Structural Biology and Drug Design, and State Local Joint Engineering Laboratory for Anticancer Drug, Xiangya Hospital, Central South University. Xianquan Zhan is currently He got his M.D. and Ph.D. degree at the West China University of Medical Sciences, and received his post-doctoral training in the field of cancer proteomics at the Hunan Medical University in China. Since 2001, he had continuously worked at the University of Tennessee Health Science Center and the Cleveland Clinic in the United States, where he focused on mass spectrometry, proteomics, and biomarker studies, and achieved the rank of Associate Professor at the University of Tennessee Health Science Center in 2010. He is also the National Representative of European Association for Predictive, Preventive and Personalized Medicine (EPMA) in China. He is also the Editor-In-Chief of International Journal of Chronic Diseases & Therapy, Associate Editors of BMC Medical Genomics, EPMA Journal, and Frontiers in Endocrinology, and Editorial Board Members of 62 international journals. He has published 100 peer-reviewed research articles (75 articles in the field of disease proteomics and transcriptomics), 8 book chapters, and 2 US patents. He focuses on the studies of cancer proteomics and biomarkers, and the use of multi-omics in personalized medicine.